
Company Number
08124358
Next Accounts
Sep 2025
Shareholders
the beachcombers trust
francesco maccioni
View AllGroup Structure
View All
Industry
Manufacture of basic pharmaceutical products
Registered Address
alders farm ivy lane, great brickhill, milton keynes, MK17 9AH
Website
www.lamicare.comPomanda estimates the enterprise value of LAMICARE HEALTH LTD at £403.6k based on a Turnover of £305.1k and 1.32x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of LAMICARE HEALTH LTD at £0 based on an EBITDA of £-184.9k and a 5.56x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of LAMICARE HEALTH LTD at £243.1k based on Net Assets of £136.4k and 1.78x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Lamicare Health Ltd is a live company located in milton keynes, MK17 9AH with a Companies House number of 08124358. It operates in the manufacture of basic pharmaceutical products sector, SIC Code 21100. Founded in June 2012, it's largest shareholder is the beachcombers trust with a 51.1% stake. Lamicare Health Ltd is a established, micro sized company, Pomanda has estimated its turnover at £305.1k with low growth in recent years.
Pomanda's financial health check has awarded Lamicare Health Ltd a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
6 Weak
Size
annual sales of £305.1k, make it smaller than the average company (£36.6m)
- Lamicare Health Ltd
£36.6m - Industry AVG
Growth
3 year (CAGR) sales growth of 3%, show it is growing at a slower rate (5.2%)
- Lamicare Health Ltd
5.2% - Industry AVG
Production
with a gross margin of 38%, this company has a comparable cost of product (38%)
- Lamicare Health Ltd
38% - Industry AVG
Profitability
an operating margin of -60.6% make it less profitable than the average company (6.8%)
- Lamicare Health Ltd
6.8% - Industry AVG
Employees
with 2 employees, this is below the industry average (111)
2 - Lamicare Health Ltd
111 - Industry AVG
Pay Structure
on an average salary of £67.6k, the company has an equivalent pay structure (£67.6k)
- Lamicare Health Ltd
£67.6k - Industry AVG
Efficiency
resulting in sales per employee of £152.6k, this is less efficient (£445.7k)
- Lamicare Health Ltd
£445.7k - Industry AVG
Debtor Days
it gets paid by customers after 35 days, this is earlier than average (56 days)
- Lamicare Health Ltd
56 days - Industry AVG
Creditor Days
its suppliers are paid after 15 days, this is quicker than average (34 days)
- Lamicare Health Ltd
34 days - Industry AVG
Stock Days
it holds stock equivalent to 12 days, this is less than average (102 days)
- Lamicare Health Ltd
102 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 192 weeks, this is more cash available to meet short term requirements (9 weeks)
192 weeks - Lamicare Health Ltd
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 19.3%, this is a lower level of debt than the average (44.8%)
19.3% - Lamicare Health Ltd
44.8% - Industry AVG
Lamicare Health Ltd's latest turnover from December 2023 is estimated at £305.1 thousand and the company has net assets of £136.4 thousand. According to their latest financial statements, Lamicare Health Ltd has 2 employees and maintains cash reserves of £121.3 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | |||||||||||
Other Income Or Grants | |||||||||||
Cost Of Sales | |||||||||||
Gross Profit | |||||||||||
Admin Expenses | |||||||||||
Operating Profit | |||||||||||
Interest Payable | |||||||||||
Interest Receivable | |||||||||||
Pre-Tax Profit | |||||||||||
Tax | |||||||||||
Profit After Tax | |||||||||||
Dividends Paid | |||||||||||
Retained Profit | |||||||||||
Employee Costs | |||||||||||
Number Of Employees | 2 | 2 | 2 | 2 | |||||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | |||||||||||
Intangible Assets | 2,848 | 5,696 | 8,544 | 11,391 | |||||||
Investments & Other | |||||||||||
Debtors (Due After 1 year) | 13,755 | 11,491 | |||||||||
Total Fixed Assets | 13,755 | 14,339 | 5,696 | 8,544 | 11,391 | ||||||
Stock & work in progress | 6,381 | 10,619 | |||||||||
Trade Debtors | 29,370 | 24,505 | 16,323 | 7,137 | 46,077 | 188,669 | |||||
Group Debtors | |||||||||||
Misc Debtors | 12,080 | 13,671 | 10,403 | 10,403 | 10,403 | ||||||
Cash | 121,284 | 176,056 | 535,021 | 383 | 3,777 | 12,211 | 247 | 43 | 7 | 66 | |
misc current assets | |||||||||||
total current assets | 169,115 | 224,851 | 561,747 | 17,923 | 56,480 | 192,446 | 12,211 | 247 | 43 | 7 | 66 |
total assets | 169,115 | 224,851 | 561,747 | 17,923 | 56,480 | 206,201 | 26,550 | 5,943 | 8,587 | 11,398 | 66 |
Bank overdraft | 10,605 | ||||||||||
Bank loan | |||||||||||
Trade Creditors | 8,175 | 16,086 | 17,506 | 17,505 | 17,505 | 138,476 | 29,089 | 16,956 | |||
Group/Directors Accounts | |||||||||||
other short term finances | |||||||||||
hp & lease commitments | |||||||||||
other current liabilities | 24,536 | 46,170 | 59,180 | 60,834 | 63,300 | 116,948 | 66,113 | 65,129 | 62,792 | ||
total current liabilities | 32,711 | 62,256 | 76,686 | 78,339 | 91,410 | 255,424 | 66,113 | 65,129 | 62,792 | 29,089 | 16,956 |
loans | |||||||||||
hp & lease commitments | |||||||||||
Accruals and Deferred Income | |||||||||||
other liabilities | |||||||||||
provisions | |||||||||||
total long term liabilities | |||||||||||
total liabilities | 32,711 | 62,256 | 76,686 | 78,339 | 91,410 | 255,424 | 66,113 | 65,129 | 62,792 | 29,089 | 16,956 |
net assets | 136,404 | 162,595 | 485,061 | -60,416 | -34,930 | -49,223 | -39,563 | -59,186 | -54,205 | -17,691 | -16,890 |
total shareholders funds | 136,404 | 162,595 | 485,061 | -60,416 | -34,930 | -49,223 | -39,563 | -59,186 | -54,205 | -17,691 | -16,890 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||
Operating Profit | |||||||||||
Depreciation | |||||||||||
Amortisation | 2,848 | 2,848 | 2,848 | 2,847 | 2,847 | ||||||
Tax | |||||||||||
Stock | -4,238 | 10,619 | |||||||||
Debtors | 3,274 | 11,450 | 9,186 | -38,940 | -145,944 | 190,933 | 11,491 | ||||
Creditors | -7,911 | -1,420 | 1 | -120,971 | 138,476 | -29,089 | 12,133 | 16,956 | |||
Accruals and Deferred Income | -21,634 | -13,010 | -1,654 | -2,466 | -53,648 | 50,835 | 984 | 2,337 | 62,792 | ||
Deferred Taxes & Provisions | |||||||||||
Cash flow from operations | |||||||||||
Investing Activities | |||||||||||
capital expenditure | |||||||||||
Change in Investments | |||||||||||
cash flow from investments | |||||||||||
Financing Activities | |||||||||||
Bank loans | |||||||||||
Group/Directors Accounts | |||||||||||
Other Short Term Loans | |||||||||||
Long term loans | |||||||||||
Hire Purchase and Lease Commitments | |||||||||||
other long term liabilities | |||||||||||
share issue | |||||||||||
interest | |||||||||||
cash flow from financing | |||||||||||
cash and cash equivalents | |||||||||||
cash | -54,772 | -358,965 | 534,638 | 383 | -3,777 | -8,434 | 11,964 | 204 | 36 | -59 | 66 |
overdraft | -10,605 | 10,605 | |||||||||
change in cash | -54,772 | -358,965 | 534,638 | 10,988 | -14,382 | -8,434 | 11,964 | 204 | 36 | -59 | 66 |
Perform a competitor analysis for lamicare health ltd by selecting its closest rivals, whether from the MANUFACTURING sector, other micro companies, companies in MK17 area or any other competitors across 12 key performance metrics.
LAMICARE HEALTH LTD group structure
Lamicare Health Ltd has no subsidiary companies.
Ultimate parent company
LAMICARE HEALTH LTD
08124358
Lamicare Health Ltd currently has 2 directors. The longest serving directors include Dr Nigel Christie (Aug 2012) and Mr Francesco MacCioni (Aug 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Dr Nigel Christie | South Africa | 77 years | Aug 2012 | - | Director |
Mr Francesco MacCioni | South Africa | 61 years | Aug 2012 | - | Director |
P&L
December 2023turnover
305.1k
+4%
operating profit
-184.9k
0%
gross margin
38.1%
+1.48%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
136.4k
-0.16%
total assets
169.1k
-0.25%
cash
121.3k
-0.31%
net assets
Total assets minus all liabilities
company number
08124358
Type
Private limited with Share Capital
industry
21100 - Manufacture of basic pharmaceutical products
incorporation date
June 2012
age
13
incorporated
UK
ultimate parent company
accounts
Total Exemption Full
last accounts submitted
December 2023
previous names
N/A
accountant
PRICE JONES PARTNERSHIP LTD
auditor
-
address
alders farm ivy lane, great brickhill, milton keynes, MK17 9AH
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to lamicare health ltd.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for LAMICARE HEALTH LTD. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|